Australia markets closed

Chemomab Therapeutics Ltd. (CMMB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.9124-0.0406 (-4.26%)
At close: 04:00PM EDT
0.9101 -0.00 (-0.25%)
After hours: 04:27PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.97M
Enterprise value -2.51M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.97
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-33.91%
S&P500 52-week change 322.55%
52-week high 31.5000
52-week low 30.4200
50-day moving average 30.8944
200-day moving average 30.7403

Share statistics

Avg vol (3-month) 398.87k
Avg vol (10-day) 396.82k
Shares outstanding 514.22M
Implied shares outstanding 611.25M
Float 8188.13M
% held by insiders 114.97%
% held by institutions 123.83%
Shares short (14 June 2024) 499.7k
Short ratio (14 June 2024) 41
Short % of float (14 June 2024) 40.71%
Short % of shares outstanding (14 June 2024) 40.70%
Shares short (prior month 15 May 2024) 4104.22k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:16
Last split date 317 Mar 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-48.23%
Return on equity (ttm)-93.67%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -20.39M
Net income avi to common (ttm)-19.34M
Diluted EPS (ttm)-1.5400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)15.88M
Total cash per share (mrq)0.06
Total debt (mrq)390k
Total debt/equity (mrq)2.93%
Current ratio (mrq)3.83
Book value per share (mrq)0.94

Cash flow statement

Operating cash flow (ttm)N/A
Levered free cash flow (ttm)N/A